Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 31, 2018 07:00 ET | Source: Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics to Hold Second Quarter 2018 Financial Results and Corporate Update Conference Call on August 9, 2018

CARMIEL, Israel, July 31, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX, TASE:PLX), a biopharmaceutical company focused on the development and commercialization of...
July 31, 2018 03:40 ET | Source: GAZIT-GLOBE LTD

Gazit Globe Announces Date for Q2 2018 Results Conference Call

TEL-AVIV, Israel, July 31, 2018 (GLOBE NEWSWIRE) -- Gazit Globe (NYSE/TSX/TASE: GZT), a leading global real estate company focused on the ownership, management and development of retail and mixed...
July 30, 2018 07:47 ET | Source: Kitov Pharma Ltd.

Kitov Announces Settlement of Shareholder Class Action Litigation

Tel Aviv, Israel, July 30, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (Nasdaq: KTOV; TASE: KTOV.TA), an innovative biopharmaceutical company, today announced that it has entered into a Stipulation...
July 26, 2018 11:20 ET | Source: Backbone Hosting Solutions Inc.

Blockchain Mining Ltd. Provides Update on Exchange of ADRs for Shares

MONTREAL and RAMAT GAN, Israel, July 26, 2018 (GLOBE NEWSWIRE) -- Blockchain Mining Ltd. (“BLCM” or the “Company”) (TASE: BLCM.TA) (OTCQX: BLLCF), subsequent to the Company’s press release of July...
July 26, 2018 10:20 ET | Source: GAZIT-GLOBE LTD

Gazit Globe Divests of its Remaining Investment in Regency Centers Corporation for Approximately USD 502 Million (NIS 1.83 billion)

TEL-AVIV, Israel, July 26, 2018 (GLOBE NEWSWIRE) -- Gazit Globe (NYSE/TSX/TASE: GZT), a leading global real estate company focused on the ownership, management and development of retail and mixed...
July 26, 2018 07:00 ET | Source: Pluristem Therapeutics, Inc.

Pluristem Granted Key Patent in Japan for Treatment of GI Following Acute Radiation Exposure

Patent covers PLX-R18’s protection of the gastrointestinal (GI) tract from radiation exposureRecent data from Fukushima University shows PLX-R18 cells significantly increased survival and enhanced the...
July 26, 2018 03:50 ET | Source: Tower Semiconductor

TowerJazz Reports Results for the Second Quarter of 2018: Revenue of $335 million with Strong Increases in Net Profit and Profit Margins over Prior Quarter

MIGDAL HAEMEK, Israel, July 26, 2018 (GLOBE NEWSWIRE) -- TowerJazz (NASDAQ:TSEM) (TASE:TSEM) reported today its results for the second quarter ended June 30, 2018. Highlights for the second...
July 25, 2018 07:00 ET | Source: Magic Software Enterprises Ltd.

Topicus Signs a $2.3 Million, Five-Year Term License Agreement with Magic Software

Deal dramatically broadens capabilities of EuroPort+, Topicus’ core financial wealth management platform, by leveraging Magic’s Solutions Or Yehuda, Israel, July 25, 2018 (GLOBE...
July 24, 2018 07:00 ET | Source: Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics Expands Partnership with Chiesi Farmaceutici to Include Exclusive U.S. Rights for the Development and Commercialization of PRX-102 (pegunigalsidase alfa) for the Treatment of Fabry Disease

Protalix to receive $25 million upfront, an additional up to $20 million in development costs and an additional up to $760 million in potential regulatory and commercial milestone payments for the...
July 23, 2018 16:05 ET | Source: Medigus Ltd.

Medigus Announces Closing of $10 Million Public Offering

OMER, Israel, July 23, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”)(NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a...